InsiderSignal.AI

InsiderSignal.ai

PRME - Prime Medicine, Inc.

Insider Purchase by Gv 2021 Gp, L.L.C. (10%)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Gv 2021 Gp, L.L.C., serving as 10% owner at Prime Medicine, Inc. (PRME), purchased 1,500,000 shares at $3.30 per share, for a total transaction value of $4,950,000.00. Following this transaction, Gv 2021 Gp, L.L.C. now holds 3,262,440 shares of PRME.

This purchase represents a 85.00% increase in Gv 2021 Gp, L.L.C.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 1, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 5, 2025, 4 days after the trade was made.

Prime Medicine, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Gv 2021 Gp, L.L.C.

Gv 2021 Gp, L.L.C.

10%

GV 2021 GP, L.L.C. is a limited liability company classified as a corporate insider and beneficial owner (10%) in securities filings, notably associated with investments in biotechnology and software firms.[[6]](https://www.nasdaq.com/market-activity/insiders/liu-david-r-985770?reqid=f57a9b15-3129-40ea-851a-27e6c4a72163)[[2]](https://fintel.io/n/gv-2021-gp-l-l-c) Established around 2021, it functions as a general partner (GP) entity, likely managing or advising investment funds, with an SEC CIK of 0001861206.[[10]](https://www.sec.gov/cgi-bin/browse-edgar?CIK=0001861206&action=getcompany)[[5]](http://openinsider.com/insider/Gv-2021-Gp--L.L.C./1861206) The firm has engaged in insider trading activities across multiple public companies, including recent transactions at Prime Medicine, Inc. (PRME) where it is listed as a 10% owner, alongside holdings in GitLab Inc. (GTLB).[[3]](https://www.gurufocus.com/insider/175575/gv-2021-gp,-l.p.)[[4]](https://www.gurufocus.com/insider/175574/gv-2021-gp,-l.l.c.)[[6]](https://www.nasdaq.com/market-activity/insiders/liu-david-r-985770?reqid=f57a9b15-3129-40ea-851a-27e6c4a72163) Its estimated net worth exceeds $112 million as of late 2025, derived from reported ownership stakes, though specific business operations, founding history, and leadership details remain undisclosed in public SEC filings and tracking databases.[[4]](https://www.gurufocus.com/insider/175574/gv-2021-gp,-l.l.c.) GV 2021 GP, L.L.C. has also appeared in transactions for companies like Alphabet Inc. (GOOG).[[1]](https://www.siriusinvestors.com/stock/GOOG/insider-trading?page=12&show=1)

View full insider profile →

Trade Price

$3.30

Quantity

1,500,000

Total Value

$4,950,000.00

Shares Owned

3,262,440

Trade Date

Friday, August 1, 2025

205 days ago

SEC Filing Date

Tuesday, August 5, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Prime Medicine, Inc.

Company Overview

No company information available
View news mentioning PRME

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/106426

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime